IBD: selective nanoparticle adhesion can enhance colitis therapy.

摘要

One of the major challenges in IBD therapy is targeting delivery of the drug to the specific site of inflammation. A recent approach to combat this problem is the use of nanoparticulate drug delivery systems that selectively accumulate a given drug at the site of affected tissue. As the drug load Is delivered locally, drug dose and adverse effects are reduced.